Discover the top 3 undervalued Health Care Equipment & Supplies stocks for Wednesday, March 19 based on AAII’s Stock Grades.

Nevro NVRO is well-poised for growth in the coming quarters, courtesy of its business expansion plans and restructuring ...

The global motion stimulation therapy market is set for significant growth, with market projections estimating its value at USD 1.4 billion in 2024. Fueled by rapid technological integration in ...

Durante la dittatura comandava un’unità di Forze speciali chiamata, senza troppa fantasia, «Le Tigri». Da sempre è vicino agli iraniani. L’ex ufficiale non ha avuto problemi a trovare ...

(ANSA) - MILANO, 06 MAR - Il Milan a Lecce è obbligato a vincere ma dovendo fare a meno di Pavlovic e Maignan entrambi squalificati. In porta quindi Sportiello mentre la coppia di centrali ...

Nevro Corp. (NYSE:NVRO – Get Free Report) has earned a consensus rating of “Reduce” from the thirteen research firms that are covering the company, Marketbeat reports. Two analysts have rated the ...

In addition to the U.S. market release, Nevro introduced the HFX iQ SCS system in select European countries in January 2025 following the receipt of CE Mark Certification in November 2024.

The company launched the full market release of HFX iQ with HFX AdaptivAI, a responsive and personalized pain management platform that powers the HFX iQ spinal cord stimulation (SCS) system. In ...

Nevro's comprehensive HFX™ spinal cord stimulation (SCS) platform includes the Senza® SCS system and support services for the treatment of chronic pain of the trunk and limb and painful ...

Management uses certain non-GAAP financial measures, most specifically adjusted EBITDA, as a supplement to GAAP financial measures to further evaluate the Company's operating performance period ...